AVITA Medical, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from AVITA Medical, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-9.4×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 50% of Healthcare companies in United States.
Cash Locked Ratio
$10For every $100 of sales, $10 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $12 tied up three years earlier.
Less money tied up than 81% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
−$59Sales grew 108% in 3 years, but profit fell: $59 less profit per $100 of extra sales.
Lower than 84% of Healthcare companies in United States.
Asset Productivity Ratio
+108% / -43%In 3 years sales changed by +108% while total assets changed by -43%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-0.7×Operating cash was negative last year, while some debt falls due within a year.
Higher than 67% of Healthcare companies in United States.
Cash Cushion Ratio
−6%Debt, after subtracting cash, equals 6% of its market value (net debt).
Lower than 75% of Healthcare companies in United States.
Tangible Assets Ratio
90%Of every $100 the company owns, $90 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 62% of Healthcare companies in United States.
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
AVITA Medical, Inc. made a loss over the last year. AVITA Medical, Inc. owes $1.58 for every $1 it owns. AVITA Medical, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossAVITA Medical, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-17.13AVITA Medical, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$477 MThe total market value of all of AVITA Medical, Inc.'s shares at today's price (share price × number of shares), larger than 54% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
NegativeAVITA Medical, Inc.'s net worth is negative ($28 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
1.58×AVITA Medical, Inc. owes $1.58 for every $1 it owns, so it owes more than it owns, higher than 95% of Healthcare companies in United States.
Dividend yield
NoneAVITA Medical, Inc. does not currently pay a dividend.
Revenue growth
+11%Revenue rose 11% in the year to Dec 2025, and grew 28% a year on average over 3 years.
Profit growth
LossAVITA Medical, Inc. made a loss in each of the last two years.
Profit margin
-67.8%AVITA Medical, Inc. lost $68 for every $100 of revenue.
Interest cover
Not coveredAVITA Medical, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtAVITA Medical, Inc. had $28 M more debt than cash (net debt) at Dec 2025.
Questions
How much does AVITA Medical, Inc. owe compared with what it owns?
AVITA Medical, Inc. owes $1.58 for every $1 it owns, so it owes more than it owns, higher than 95% of Healthcare companies in United States.
Does AVITA Medical, Inc. pay a dividend?
No. AVITA Medical, Inc. does not currently pay a dividend.
Is AVITA Medical, Inc.'s revenue growing?
Revenue rose 11% in the year to Dec 2025, and grew 28% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.